<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05052619</url>
  </required_header>
  <id_info>
    <org_study_id>Lac-infection</org_study_id>
    <nct_id>NCT05052619</nct_id>
  </id_info>
  <brief_title>Preventive Therapy of Postoperative Intra-abdominal Infection Based on Serum Lactate Changes</brief_title>
  <official_title>A Prospective, Randomized Clinical Trial to Treat Intra-abdominal Infection Preventively After Pancreatic Surgery Based on Serum Lactate Changes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intra-abdominal infection is one of the most serious complications after pancreatic&#xD;
      resection. The preventive use of antibiotics intraoperatively could reduce the incidence rate&#xD;
      of postoperative intra-abdominal infection. According to the previous retrospective study,&#xD;
      changes of serum lactate level on postoperative day1 could predict the incidence rate of&#xD;
      postoperative intra-abdominal infection. This prospective RCT is to further validate and&#xD;
      promote the findings and conclusion.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Postoperative intra-abdominal infection is one of the most serious complications after&#xD;
      pancreatic resection. Once diagnosed as postoperative intra-abdominal infection, the patient&#xD;
      would not only suffer a lot, but also spend much more money and time in hospital. Moreover,&#xD;
      subsequent sepsis and septic shock would imperil the patient's life. The preventive use of&#xD;
      antibiotics intraoperatively is the key to prevent this complication, but the time, dosage,&#xD;
      and choice of the antibiotics are worth discussing. According to the previous work, the&#xD;
      investigators found the changes in serum lactate level on postoperative day (POD) 1 could&#xD;
      predict postoperative intra-abdominal infection one week before it really happened. The&#xD;
      cutoff level of lactate is 3.25mmol/L. Thus, the investigators recommend preventive use of&#xD;
      advanced antibiotics for patients who have a peak serum lactate level of &gt;3.250 mmol/L in 24h&#xD;
      after pancreatic resection (doi: 10.1007/s00268-021-05987-8. PMID: 33604712).&#xD;
&#xD;
      The investigators would verify the finding in this randomized controlled trial. Patients with&#xD;
      peak lactate level &gt;3.250 mmol/L in POD1 and met other inclusion criteria would be recruited&#xD;
      and separated into &quot;preventive use of advanced antibiotics group&quot; (experimental group) and&#xD;
      &quot;routine group&quot; (control group) randomly. Patients in experimental group would be treated&#xD;
      with advanced antibiotics to avoid postoperative intra-abdominal infection. Patients in&#xD;
      control group would be treated with routine method (antibiotics with lower levels). To&#xD;
      compare the incidence rate of infection and other complications, as well as the payment and&#xD;
      other index, the investigators would see if the patients in experimental group could have&#xD;
      better prognosis after pancreatic surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2021</start_date>
  <completion_date type="Anticipated">July 1, 2026</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence rate of postoperative intra-abdominal infection</measure>
    <time_frame>in 30 days after surgery</time_frame>
    <description>The incidence rate of postoperative intra-abdominal infection is expected to be lower in experimental group than control group</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The amount of white blood cell</measure>
    <time_frame>postoperative days 1, 3, 5, 7, 14, 21, 28</time_frame>
    <description>It is expected to be lower in experimental group than in control group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The level of procalcitonin</measure>
    <time_frame>postoperative days 1, 3, 5, 7, 14, 21, 28</time_frame>
    <description>It is expected to be lower in experimental group than in control group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The level of C-reactive protein</measure>
    <time_frame>postoperative days 1, 3, 5, 7, 14, 21, 28</time_frame>
    <description>It is expected to be lower in experimental group than in control group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The level of interleukin</measure>
    <time_frame>postoperative days 1, 3, 5, 7, 14, 21, 28</time_frame>
    <description>It is expected to be lower in experimental group than in control group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The level of tumor necrosis factor Î±</measure>
    <time_frame>postoperative days 1, 3, 5, 7, 14, 21, 28</time_frame>
    <description>It is expected to be lower in experimental group than in control group</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">297</enrollment>
  <condition>Postoperative Infection</condition>
  <condition>Lactate</condition>
  <condition>Antibiotics</condition>
  <arm_group>
    <arm_group_label>Preventive use of advanced antibiotics group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treat patients in this group with advanced preventive usage of antibiocs: Sulperazon 3g q8h, in postoperative days 1-5.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Routine group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Treat patients in this group with routine preventive usage of antibiocs: Cefmetazole 1g q12h, in postoperative days 1-3.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Preventive use of advanced antibiotics</intervention_name>
    <description>Treat patients in this group with advanced preventive usage of antibiocs: Sulperazon 3g q8h, in postoperative days 1-5.</description>
    <arm_group_label>Preventive use of advanced antibiotics group</arm_group_label>
    <other_name>Sulperazon</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Routine</intervention_name>
    <description>Treat patients in this group with routine preventive usage of antibiocs: Cefmetazole 1g q12h, in postoperative days 1-3.</description>
    <arm_group_label>Routine group</arm_group_label>
    <other_name>Cefmetazole</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. treatment by pancreatic resection, including pancreaticoduodenectomy,&#xD;
             pancreatosplenectomy, total pancreatectomy, and other variant operations;&#xD;
&#xD;
          2. revival in the intensive care unit (ICU) with standard serum lactate elution&#xD;
             treatments after surgery instead of the operation room or general ward;&#xD;
&#xD;
          3. availability of complete preoperative, intraoperative, and postoperative data;&#xD;
&#xD;
          4. the peak serum lactate level in 24 hours after surgery &gt;3.250 mmol/L.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. a history of surgical treatment of any upper abdominal lesions before the current&#xD;
             hospital admission;&#xD;
&#xD;
          2. the minimum mean arterial pressure &lt;65 mmHg during the operation;&#xD;
&#xD;
          3. without written informed consents for the perioperative situation and related studies.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yatong Li, MD</last_name>
    <role>Study Director</role>
    <affiliation>Peking Union Medical College Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yatong Li, MD</last_name>
    <phone>861069158547</phone>
    <email>yatongli@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yatong Li, MD</last_name>
      <phone>861069158547</phone>
      <email>yatongli@qq.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://pubmed.ncbi.nlm.nih.gov/33604712/</url>
    <description>Previous work of this RCT: the retrospective study</description>
  </link>
  <results_reference>
    <citation>Li Y, Chen L, Xing C, Ding C, Zhang H, Wang S, Long Y, Guo J, Liao Q, Zhang T, Zhao Y, Dai M. Changes in Serum Lactate Level Predict Postoperative Intra-Abdominal Infection After Pancreatic Resection. World J Surg. 2021 Jun;45(6):1877-1886. doi: 10.1007/s00268-021-05987-8. Epub 2021 Feb 18.</citation>
    <PMID>33604712</PMID>
  </results_reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 12, 2021</study_first_submitted>
  <study_first_submitted_qc>September 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 22, 2021</study_first_posted>
  <last_update_submitted>September 21, 2021</last_update_submitted>
  <last_update_submitted_qc>September 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Serum lactate</keyword>
  <keyword>Postoperative intra-abdominal infection</keyword>
  <keyword>Preventive usage</keyword>
  <keyword>Advanced antibioties</keyword>
  <keyword>Strategy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Intraabdominal Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Cefmetazole</mesh_term>
    <mesh_term>Sulperazone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

